Article Search

Microbiology and Biotechnology Letters


View PDF

Microbial Biotechnology (MB)  |  Synthetic Biology and Metabolic Engineering

Microbiol. Biotechnol. Lett. 2021; 49(4): 534-542

Received: November 5, 2021; Revised: November 24, 2021; Accepted: November 24, 2021

CRISPR 간섭에 필요한 sgRNA 표적 인식 서열 길이의 결정

Determination of the Length of Target Recognition Sequence in sgRNA Required for CRISPR Interference

Bumjoon Kim, Byeong Chan Kim, Ho Joung Lee, and Sang Jun Lee*

Department of Systems Biotechnology, Chung-Ang University, Anseong 17546, Republic of Korea

Correspondence to :
Sang Jun Lee,

Single-molecular guide RNA (sgRNA) plays a role in recognizing the DNA target sequence in CRISPR technology for genome editing and gene expression control. In this study, we systematically compared the length of the target recognition sequence in sgRNAs required for genome editing using Cas9-NG (an engineered Cas9 recognizing 5’-NG as PAM sequence) and gene expression control using deactivated Cas9-NG (dCas9-NG) by targeting the gal promoter in E. coli. In the case of genome editing, the truncation of three nucleotides in the target recognition sequence (TRS) of sgRNA was allowed. In gene expression regulation, we observed that target recognition and binding were possible even if eleven nucleotides were deleted from twenty nucleotides of the TRS. When 4 or more nucleotides are truncated in the TRS of the sgRNA, it is thought that the sgRNA/Cas9-NG complex can specifically bind to the target DNA sequence, but lacks endonuclease activity to perform genome editing. Our study will be helpful in the development of artificial transcription factors and various CRISPR technologies in the field of synthetic biology.

Keywords: CRISPR interference, single-molecular guide RNA, gal promoter, D-galactose

Graphical Abstract

  1. Jansen R, van Embden JDA, Gaastra W, Schouls LM. 2002. Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43: 1565-1575.
  2. Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-170.
  3. Lee HJ, Lee SJ. 2021. Advances in accurate microbial genomeediting CRISPR technologies. J. Microbiol. Biotechnol. 31: 903911.
  4. Jinek M, Jiang F, Taylor DW, Sternberg SH, Kaya E, Ma E, et al. 2014. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343: 1247997.
    Pubmed KoreaMed
  5. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
    Pubmed KoreaMed
  6. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNAguided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31: 233-239.
    Pubmed KoreaMed
  7. Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
    Pubmed KoreaMed
  8. Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, et al. 2018. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361: 1259-1262.
    Pubmed KoreaMed
  9. Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. 2013. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41: 7429-7437.
    Pubmed KoreaMed
  10. Larson MH, Gilbert LA, Wang X, Lim WA, Weissman JS, Qi LS. 2013. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8: 2180-2196.
    Pubmed KoreaMed
  11. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, et al. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173-1183.
    Pubmed KoreaMed
  12. Fu YF, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32: 279-284.
    Pubmed KoreaMed
  13. Lee HJ, Kim HJ, Lee SJ. 2021. Mismatch intolerance of 5'-truncated sgRNAs in CRISPR/Cas9 enables efficient microbial single-base genome editing. Int. J. Mol. Sci. 22: 6457.
    Pubmed KoreaMed
  14. Moghadam F, LeGraw R, Velazquez JJ, Yeo NC, Xu C, Park J, et al. 2020. Synthetic immunomodulation with a CRISPR superrepressor in vivo. Nat. Cell Biol. 22: 1143-1154.
    Pubmed KoreaMed
  15. Kim B, Kim HJ, Lee SJ. 2020. Effective blocking of microbial transcriptional initiation by dCas9-NG-mediated CRISPR interference. J. Microbiol. Biotechnol. 30: 1919-1926.
  16. Lee HJ, Kim HJ, Lee SJ. 2020. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs. Genome Res. 30: 768-775.
    Pubmed KoreaMed
  17. Kim B, Kim HJ, Lee SJ. 2020. Regulation of microbial metabolic rates using CRISPR interference with expanded PAM sequences. Front. Microbiol. 11: 282.
    Pubmed KoreaMed
  18. Khakimzhan A, Garenne D, Tickman B, Fontana J, Carothers J, Noireaux V. 2021. Complex dependence of CRISPR-Cas9 binding strength on guide RNA spacer lengths. Phys. Biol. 18:056003.

Starts of Metrics

Share this article on :

  • mail

Related articles in MBL

Most KeyWord ?

What is Most Keyword?

  • It is most registrated keyword in articles at this journal during for 2 years.